Takashi et al. and Chen et al. discovered that abnormal ADCY5 expression was correlated to tumor aggressiveness and DNA Methylation of ADCY5 might lead to unsatisfied outcomes for patients with lung cancer [113, 114]. The gene discussed is ADCY5; the disease is neoplasm.